Cargando…

High DCR and Better Survival in Patients with Advanced or Metastatic Gastric Cancer Receiving Anti-Angiogenic TKI plus Chemotherapy: A Real-World Study

Objectives: This study was carried out to assess the efficacy and drug toxicity of anti-angiogenic tyrosine kinase inhibitor (TKI) plus chemotherapy as second-line or above therapeutic regime in advanced or metastatic gastric cancer patients. Methods: From November 2017 to April 2020, advanced or me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nie, Caiyun, Lv, Huifang, Chen, Beibei, Xu, Weifeng, Wang, Jianzheng, Wang, Saiqi, Liu, Yingjun, He, Yunduan, Zhao, Jing, Chen, Xiaobing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982383/ https://www.ncbi.nlm.nih.gov/pubmed/36632666 http://dx.doi.org/10.1177/15330338221150561

Ejemplares similares

Microsatellite stable metastatic colorectal cancer without liver metastasis may be preferred population for regorafenib or fruquintinib plus sintilimab as third-line or above therapy:A real-world study
por: Nie, Caiyun, et al.
Publicado: (2022)

Tailoring second-line or above therapy for patients with advanced or metastatic gastric cancer: A multicenter real-world study
por: Nie, Caiyun, et al.
Publicado: (2022)

Molecular subtypes based on Wnt-signaling gene expression predict prognosis and tumor microenvironment in hepatocellular carcinoma
por: Xu, Weifeng, et al.
Publicado: (2022)

Efficacy of regorafenib combined with PD-1 inhibitors in elderly patients with advanced metastatic colorectal cancer
por: Chen, Beibei, et al.
Publicado: (2022)

Clinical Study of Anlotinib as Third-Line or Above Therapy in Patients With Advanced or Metastatic Gastric Cancer: A Multicenter Retrospective Study
por: Nie, Caiyun, et al.
Publicado: (2022)

Expression of Human Epidermal Growth Factor Receptor-2 Status and Programmed Cell Death Protein-1 Ligand Is Associated With Prognosis in Gastric Cancer
por: Lv, Huifang, et al.
Publicado: (2021)

Corrigendum: Expression of Human Epidermal Growth Factor Receptor-2 Status and Programmed Cell Death Protein-1 Ligand Is Associated With Prognosis in Gastric Cancer
por: Lv, Huifang, et al.
Publicado: (2021)

Clinical Study of Sintilimab as Second-Line or Above Therapy in Patients With Advanced or Metastatic Gastric Cancer: A Retrospective Study
por: Nie, Caiyun, et al.
Publicado: (2021)

Dawning precision treatment for gastric cancer: The latest biomarkers
por: Sun, Keran, et al.
Publicado: (2021)

The Efficacy and Safety of Sintilimab Combined With Nab-Paclitaxel as a Second-Line Treatment for Advanced or Metastatic Gastric Cancer and Gastroesophageal Junction Cancer
por: Wang, Jianzheng, et al.
Publicado: (2022)

Retrospective Study on the Efficacy and Safety of Pyrotinib-Based Therapy for HER2-Positive Nonbreast Advanced Solid Tumors
por: Wang, Jianzheng, et al.
Publicado: (2022)

The efficacy and safety of apatinib treatment for patients with advanced or recurrent biliary tract cancer: a retrospective study
por: Nie, Caiyun, et al.
Publicado: (2021)

Adding of apatinib and camrelizumab to overcome de novo trastuzumab resistance of HER2-positive gastric cancer: A case report and literature review
por: Lv, Huifang, et al.
Publicado: (2023)

Overview on the Role of E-Cadherin in Gastric Cancer: Dysregulation and Clinical Implications
por: Zhao, Huichen, et al.
Publicado: (2021)

A PD-1 Inhibitor Induces Complete Response of Advanced Bladder Urothelial Carcinoma: A Case Report
por: Wang, Jianzheng, et al.
Publicado: (2021)

Endoscopic and external dacryocystorhinostomy (DCR) - which is better?
por: Wormald, Peter John, et al.
Publicado: (2015)

Combination of Anlotinib and Celecoxib for the Treatment of Abdominal Desmoid Tumor: A Case Report and Literature Review
por: Wang, Jianzheng, et al.
Publicado: (2022)

Knockdown of Kremen2 Inhibits Tumor Growth and Migration in Gastric Cancer
por: Chen, Beibei, et al.
Publicado: (2021)

Endoscopic DCR vs External DCR: What's Best in the Acute Setting?
por: Amadi, Arash J.
Publicado: (2017)

Personalized Treatment of Advanced Gastric Cancer Guided by the MiniPDX Model
por: Wang, Jianzheng, et al.
Publicado: (2022)

A new approach to endoscopic DCR
por: Singh, Amit Pal, et al.
Publicado: (2015)

Modified external revision-DCR in previous failed endonasal, transcanalicular or external-DCR: technical strategy and teaching Pearls for success
por: Evereklioglu, Cem, et al.
Publicado: (2023)

Research Progress of DcR3 in the Diagnosis and Treatment of Sepsis
por: Su, Jingqian, et al.
Publicado: (2023)

MicroRNA-6884-5p Regulates the Proliferation, Invasion, and EMT of Gastric Cancer Cells by Directly Targeting S100A16
por: Lv, Huifang, et al.
Publicado: (2020)

GATA4 and DcR1 methylation in glioblastomas
por: Vaitkienė, Paulina, et al.
Publicado: (2013)

Dacryocystorhinostomy ostium: parameters to evaluate and DCR ostium scoring
por: Ali, Mohammad Javed, et al.
Publicado: (2014)

The Endoscopic Endonasal Dacryocystorhinostomy (eDCR) in the Immunocompromised Patient
por: Lunardi, G., et al.
Publicado: (2023)

EGFR-TKI Plus Anti-Angiogenic Drugs in EGFR-Mutated Non–Small Cell Lung Cancer: A Meta-Analysis of Randomized Clinical Trials
por: Conforti, Fabio, et al.
Publicado: (2020)

DcR3, a new biomarker for sepsis, correlates with infection severity and procalcitonin
por: Gao, Liqin, et al.
Publicado: (2017)

Medical aspects of terrorist bombings – a focus on DCS and DCR
por: Mutafchiyski, Ventsislav M, et al.
Publicado: (2014)

Shifting to very early endoscopic DCR in acute suppurative dacryocystitis
por: Pakdel, Farzad, et al.
Publicado: (2019)

Decoy receptor 1 (DCR1) promoter hypermethylation and response to irinotecan in metastatic colorectal cancer
por: Bosch, Linda J.W., et al.
Publicado: (2017)

Overexpression of DcR3 and Its Significance on Tumor Cell Differentiation and Proliferation in Glioma
por: Huang, Suning, et al.
Publicado: (2014)

Hypoxia-inducible factor 1-alpha expression correlates with response to neoadjuvant chemotherapy in women with breast cancer
por: Nie, Caiyun, et al.
Publicado: (2018)

Electrostatic Steering Accelerates C3d:CR2 Association
por: Mohan, Rohith R., et al.
Publicado: (2016)

Amelioration of amyloid-β-induced deficits by DcR3 in an Alzheimer’s disease model
por: Liu, Yi-Ling, et al.
Publicado: (2017)

Lightweight Network DCR-YOLO for Surface Defect Detection on Printed Circuit Boards
por: Jiang, Yuanyuan, et al.
Publicado: (2023)

DCR for nasolacrimal duct stenosis may be less effective than for complete obstruction
por: Shapira, Yinon, et al.
Publicado: (2022)

HER2 Amplification in Advanced NSCLC Patients After Progression on EGFR-TKI and Clinical Response to EGFR-TKI Plus Pyrotinib Combination Therapy
por: Gan, Jiadi, et al.
Publicado: (2021)

DcR3 combined with hematological traits serves as a valuable biomarker for the diagnosis of cancer metastasis
por: Li, Junxin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_43bjsaop72sa5eurrdk7b6ubqc